Showing results (1491-1500 of 4,599) with videos related to

Sort By:
Pageof 460
Chemmedchem|May 13, 2022
Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor SubtypeAntonios Drakopoulos, Dimitrios Moianos, Georgia-Myrto Prifti, et al.
Chemmedchem|July 21, 2021
25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A ReceptorEmil Märcher Rørsted, Anders A Jensen, Jesper L Kristensen
Chemmedchem|July 21, 2021
A Patent Review on the Current Developments of Benzoxazoles in Drug DiscoveryXi Khai Wong, Keng Yoon Yeong
Chemmedchem|July 26, 2021
Inhibitors of Human Divalent Metal Transporters DMT1 (SLC11A2) and ZIP8 (SLC39A8) from a GDB-17 Fragment LibraryJonai Pujol-Giménez, Marion Poirier, Sven Bühlmann, et al.
Chemmedchem|July 26, 2021
Chalcone-Supported Cardiac Mesoderm Induction in Human Pluripotent Stem Cells for Heart Muscle EngineeringFarah S Raad, Taukeer A Khan, Tilman U Esser, et al.
Chemmedchem|June 17, 2021
A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline CoreJavier García-Marín, Mercedes Griera, Ramón Alajarín, et al.
Chemmedchem|December 26, 2017
The Anticancer Potential of Peroxisome Proliferator-Activated Receptor AntagonistsLaura De Lellis, Annamaria Cimini, Serena Veschi, et al.
Chemmedchem|October 10, 2017
Minor Structural Variations of Small Molecules Tune Regulatory Activities toward Pathological Factors in Alzheimer's DiseaseMichael W Beck, Jeffrey S Derrick, Jong-Min Suh, et al.
Chemmedchem|September 30, 2017
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of CancerUlrich Lücking, Arne Scholz, Philip Lienau, et al.
Chemmedchem|May 24, 2023
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in CancerNatalie Fuchs, Mergim Meta, Bellinda Lantzberg, et al.
Pageof 460